Serine Proteases from Nematode and Protozoan Parasites
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
A Rationale for Targeting Sentinel Innate Immune Signaling of Group 1 House Dust Mite Allergens Th
Molecular Pharmacology Fast Forward. Published on July 5, 2018 as DOI: 10.1124/mol.118.112730 This article has not been copyedited and formatted. The final version may differ from this version. MOL #112730 1 Title Page MiniReview for Molecular Pharmacology Allergen Delivery Inhibitors: A Rationale for Targeting Sentinel Innate Immune Signaling of Group 1 House Dust Mite Allergens Through Structure-Based Protease Inhibitor Design Downloaded from molpharm.aspetjournals.org Jihui Zhang, Jie Chen, Gary K Newton, Trevor R Perrior, Clive Robinson at ASPET Journals on September 26, 2021 Institute for Infection and Immunity, St George’s, University of London, Cranmer Terrace, London SW17 0RE, United Kingdom (JZ, JC, CR) State Key Laboratory of Microbial Resources, Institute of Microbiology, Chinese Academy of Sciences, Beijing, P.R. China (JZ) Domainex Ltd, Chesterford Research Park, Little Chesterford, Saffron Walden, CB10 1XL, United Kingdom (GKN, TRP) Molecular Pharmacology Fast Forward. Published on July 5, 2018 as DOI: 10.1124/mol.118.112730 This article has not been copyedited and formatted. The final version may differ from this version. MOL #112730 2 Running Title Page Running Title: Allergen Delivery Inhibitors Correspondence: Professor Clive Robinson, Institute for Infection and Immunity, St George’s, University of London, SW17 0RE, UK [email protected] Downloaded from Number of pages: 68 (including references, tables and figures)(word count = 19,752) 26 (main text)(word count = 10,945) Number of Tables: 3 molpharm.aspetjournals.org -
High Molecular Weight Kininogen Is an Inhibitor of Platelet Calpain
High molecular weight kininogen is an inhibitor of platelet calpain. A H Schmaier, … , D Schutsky, R W Colman J Clin Invest. 1986;77(5):1565-1573. https://doi.org/10.1172/JCI112472. Research Article Recent studies from our laboratory indicate that a high concentration of platelet-derived calcium-activated cysteine protease (calpain) can cleave high molecular weight kininogen (HMWK). On immunodiffusion and immunoblot, antiserum directed to the heavy chain of HMWK showed immunochemical identity with alpha-cysteine protease inhibitor--a major plasma inhibitor of tissue calpains. Studies were then initiated to determine whether purified or plasma HMWK was also an inhibitor of platelet calpain. Purified alpha-cysteine protease inhibitor, alpha-2-macroglobulin, as well as purified heavy chain of HMWK or HMWK itself inhibited purified platelet calpain. Kinetic analysis revealed that HMWK inhibited platelet calpain noncompetitively (Ki approximately equal to 5 nM). Incubation of platelet calpain with HMWK, alpha-2- macroglobulin, purified heavy chain of HMWK, or purified alpha-cysteine protease inhibitor under similar conditions resulted in an IC50 of 36, 500, 700, and 1,700 nM, respectively. The contribution of these proteins in plasma towards the inhibition of platelet calpain was investigated next. Normal plasma contained a protein that conferred a five to sixfold greater IC50 of purified platelet calpain than plasma deficient in either HMWK or total kininogen. Reconstitution of total kininogen deficient plasma with purified HMWK to normal levels (0.67 microM) completely corrected the subnormal inhibitory activity. However, reconstitution of HMWK deficient plasma to normal levels of low molecular weight kininogen (2.4 microM) did not fully correct the subnormal calpain inhibitory capacity […] Find the latest version: https://jci.me/112472/pdf High Molecular Weight Kininogen Is an Inhibitor of Platelet Calpain Alvin H. -
VEGF-A Induces Angiogenesis by Perturbing the Cathepsin-Cysteine
Published OnlineFirst May 12, 2009; DOI: 10.1158/0008-5472.CAN-08-4539 Published Online First on May 12, 2009 as 10.1158/0008-5472.CAN-08-4539 Research Article VEGF-A Induces Angiogenesis by Perturbing the Cathepsin-Cysteine Protease Inhibitor Balance in Venules, Causing Basement Membrane Degradation and Mother Vessel Formation Sung-Hee Chang,1 Keizo Kanasaki,2 Vasilena Gocheva,4 Galia Blum,5 Jay Harper,3 Marsha A. Moses,3 Shou-Ching Shih,1 Janice A. Nagy,1 Johanna Joyce,4 Matthew Bogyo,5 Raghu Kalluri,2 and Harold F. Dvorak1 Departments of 1Pathology and 2Medicine, and the Center for Vascular Biology Research, Beth Israel Deaconess Medical Center and Harvard Medical School, and 3Departments of Surgery, Children’s Hospital and Harvard Medical School, Boston, Massachusetts; 4Cancer Biology and Genetics Program, Memorial Sloan-Kettering Cancer Center, New York, New York; and 5Department of Pathology, Stanford University, Stanford, California Abstract to form in many transplantable mouse tumor models are mother Tumors initiate angiogenesis primarily by secreting vascular vessels (MV), a blood vessel type that is also common in many endothelial growth factor (VEGF-A164). The first new vessels autochthonous human tumors (2, 3, 6–8). MV are greatly enlarged, to form are greatly enlarged, pericyte-poor sinusoids, called thin-walled, hyperpermeable, pericyte-depleted sinusoids that form mother vessels (MV), that originate from preexisting venules. from preexisting venules. The dramatic enlargement of venules We postulated that the venular enlargement necessary to form leading to MV formation would seem to require proteolytic MV would require a selective degradation of their basement degradation of their basement membranes. -
Chapter 11 Cysteine Proteases
CHAPTER 11 CYSTEINE PROTEASES ZBIGNIEW GRZONKA, FRANCISZEK KASPRZYKOWSKI AND WIESŁAW WICZK∗ Faculty of Chemistry, University of Gdansk,´ Poland ∗[email protected] 1. INTRODUCTION Cysteine proteases (CPs) are present in all living organisms. More than twenty families of cysteine proteases have been described (Barrett, 1994) many of which (e.g. papain, bromelain, ficain , animal cathepsins) are of industrial impor- tance. Recently, cysteine proteases, in particular lysosomal cathepsins, have attracted the interest of the pharmaceutical industry (Leung-Toung et al., 2002). Cathepsins are promising drug targets for many diseases such as osteoporosis, rheumatoid arthritis, arteriosclerosis, cancer, and inflammatory and autoimmune diseases. Caspases, another group of CPs, are important elements of the apoptotic machinery that regulates programmed cell death (Denault and Salvesen, 2002). Comprehensive information on CPs can be found in many excellent books and reviews (Barrett et al., 1998; Bordusa, 2002; Drauz and Waldmann, 2002; Lecaille et al., 2002; McGrath, 1999; Otto and Schirmeister, 1997). 2. STRUCTURE AND FUNCTION 2.1. Classification and Evolution Cysteine proteases (EC.3.4.22) are proteins of molecular mass about 21-30 kDa. They catalyse the hydrolysis of peptide, amide, ester, thiol ester and thiono ester bonds. The CP family can be subdivided into exopeptidases (e.g. cathepsin X, carboxypeptidase B) and endopeptidases (papain, bromelain, ficain, cathepsins). Exopeptidases cleave the peptide bond proximal to the amino or carboxy termini of the substrate, whereas endopeptidases cleave peptide bonds distant from the N- or C-termini. Cysteine proteases are divided into five clans: CA (papain-like enzymes), 181 J. Polaina and A.P. MacCabe (eds.), Industrial Enzymes, 181–195. -
The Role of Cysteine Cathepsins in Cancer Progression and Drug Resistance
International Journal of Molecular Sciences Review The Role of Cysteine Cathepsins in Cancer Progression and Drug Resistance Magdalena Rudzi ´nska 1, Alessandro Parodi 1, Surinder M. Soond 1, Andrey Z. Vinarov 2, Dmitry O. Korolev 2, Andrey O. Morozov 2, Cenk Daglioglu 3 , Yusuf Tutar 4 and Andrey A. Zamyatnin Jr. 1,5,* 1 Institute of Molecular Medicine, Sechenov First Moscow State Medical University, 119991 Moscow, Russia 2 Institute for Urology and Reproductive Health, Sechenov University, 119992 Moscow, Russia 3 Izmir Institute of Technology, Faculty of Science, Department of Molecular Biology and Genetics, 35430 Urla/Izmir, Turkey 4 Faculty of Pharmacy, University of Health Sciences, 34668 Istanbul, Turkey 5 Belozersky Institute of Physico-Chemical Biology, Lomonosov Moscow State University, 119991 Moscow, Russia * Correspondence: [email protected]; Tel.: +7-4956229843 Received: 26 June 2019; Accepted: 19 July 2019; Published: 23 July 2019 Abstract: Cysteine cathepsins are lysosomal enzymes belonging to the papain family. Their expression is misregulated in a wide variety of tumors, and ample data prove their involvement in cancer progression, angiogenesis, metastasis, and in the occurrence of drug resistance. However, while their overexpression is usually associated with highly aggressive tumor phenotypes, their mechanistic role in cancer progression is still to be determined to develop new therapeutic strategies. In this review, we highlight the literature related to the role of the cysteine cathepsins in cancer biology, with particular emphasis on their input into tumor biology. Keywords: cysteine cathepsins; cancer progression; drug resistance 1. Introduction Cathepsins are lysosomal proteases and, according to their active site, they can be classified into cysteine, aspartate, and serine cathepsins [1]. -
Proteolytic Cleavage—Mechanisms, Function
Review Cite This: Chem. Rev. 2018, 118, 1137−1168 pubs.acs.org/CR Proteolytic CleavageMechanisms, Function, and “Omic” Approaches for a Near-Ubiquitous Posttranslational Modification Theo Klein,†,⊥ Ulrich Eckhard,†,§ Antoine Dufour,†,¶ Nestor Solis,† and Christopher M. Overall*,†,‡ † ‡ Life Sciences Institute, Department of Oral Biological and Medical Sciences, and Department of Biochemistry and Molecular Biology, University of British Columbia, Vancouver, British Columbia V6T 1Z4, Canada ABSTRACT: Proteases enzymatically hydrolyze peptide bonds in substrate proteins, resulting in a widespread, irreversible posttranslational modification of the protein’s structure and biological function. Often regarded as a mere degradative mechanism in destruction of proteins or turnover in maintaining physiological homeostasis, recent research in the field of degradomics has led to the recognition of two main yet unexpected concepts. First, that targeted, limited proteolytic cleavage events by a wide repertoire of proteases are pivotal regulators of most, if not all, physiological and pathological processes. Second, an unexpected in vivo abundance of stable cleaved proteins revealed pervasive, functionally relevant protein processing in normal and diseased tissuefrom 40 to 70% of proteins also occur in vivo as distinct stable proteoforms with undocumented N- or C- termini, meaning these proteoforms are stable functional cleavage products, most with unknown functional implications. In this Review, we discuss the structural biology aspects and mechanisms -
Virtual Screening of Anti-HIV1 Compounds Against SARS-Cov-2
www.nature.com/scientificreports OPEN Virtual screening of anti‑HIV1 compounds against SARS‑CoV‑2: machine learning modeling, chemoinformatics and molecular dynamics simulation based analysis Mahesha Nand1,6, Priyanka Maiti 2,6*, Tushar Joshi3, Subhash Chandra4*, Veena Pande3, Jagdish Chandra Kuniyal2 & Muthannan Andavar Ramakrishnan5* COVID‑19 caused by the SARS‑CoV‑2 is a current global challenge and urgent discovery of potential drugs to combat this pandemic is a need of the hour. 3‑chymotrypsin‑like cysteine protease (3CLpro) enzyme is the vital molecular target against the SARS‑CoV‑2. Therefore, in the present study, 1528 anti‑HIV1compounds were screened by sequence alignment between 3CLpro of SARS‑CoV‑2 and avian infectious bronchitis virus (avian coronavirus) followed by machine learning predictive model, drug‑likeness screening and molecular docking, which resulted in 41 screened compounds. These 41 compounds were re‑screened by deep learning model constructed considering the IC50 values of known inhibitors which resulted in 22 hit compounds. Further, screening was done by structural activity relationship mapping which resulted in two structural clefts. Thereafter, functional group analysis was also done, where cluster 2 showed the presence of several essential functional groups having pharmacological importance. In the fnal stage, Cluster 2 compounds were re‑docked with four diferent PDB structures of 3CLpro, and their depth interaction profle was analyzed followed by molecular dynamics simulation at 100 ns. Conclusively, 2 out of 1528 compounds were screened as potential hits against 3CLpro which could be further treated as an excellent drug against SARS‑CoV‑2. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is the causative agent of the COVID-19. -
Activity-Based Profiling of Proteases
BI83CH11-Bogyo ARI 3 May 2014 11:12 Activity-Based Profiling of Proteases Laura E. Sanman1 and Matthew Bogyo1,2,3 Departments of 1Chemical and Systems Biology, 2Microbiology and Immunology, and 3Pathology, Stanford University School of Medicine, Stanford, California 94305-5324; email: [email protected] Annu. Rev. Biochem. 2014. 83:249–73 Keywords The Annual Review of Biochemistry is online at biochem.annualreviews.org activity-based probes, proteomics, mass spectrometry, affinity handle, fluorescent imaging This article’s doi: 10.1146/annurev-biochem-060713-035352 Abstract Copyright c 2014 by Annual Reviews. All rights reserved Proteolytic enzymes are key signaling molecules in both normal physi- Annu. Rev. Biochem. 2014.83:249-273. Downloaded from www.annualreviews.org ological processes and various diseases. After synthesis, protease activity is tightly controlled. Consequently, levels of protease messenger RNA by Stanford University - Main Campus Lane Medical Library on 08/28/14. For personal use only. and protein often are not good indicators of total protease activity. To more accurately assign function to new proteases, investigators require methods that can be used to detect and quantify proteolysis. In this review, we describe basic principles, recent advances, and applications of biochemical methods to track protease activity, with an emphasis on the use of activity-based probes (ABPs) to detect protease activity. We describe ABP design principles and use case studies to illustrate the ap- plication of ABPs to protease enzymology, discovery and development of protease-targeted drugs, and detection and validation of proteases as biomarkers. 249 BI83CH11-Bogyo ARI 3 May 2014 11:12 gens that contain inhibitory prodomains that Contents must be removed for the protease to become active. -
Endogenous Inhibitor for Calcium-Dependent Cysteine
Proc. Nati. Acad. Sci. USA Vol. 84, pp. 3590-3594, June 1987 Biochemistry Endogenous inhibitor for calcium-dependent cysteine protease contains four internal repeats that could be responsible for its multiple reactive sites YASUFUMI EMORI*, HIROSHI KAWASAKI*, SHINOBU IMAJOH*, KAZUTOMO IMAHORIt, AND KoICHI SUZUKI* *Department of Molecular Biology, The Tokyo Metropolitan Institute of Medical Science, Honkomagome, Bunkyo-ku, Tokyo 113, Japan; and tMitsubishi-Kasei Institute of Life Sciences, 11 Minamiooya, Machida-shi, Tokyo 194, Japan Communicated by H. A. Scheraga, February 2, 1987 ABSTRACT A cDNA encoding an endogenous inhibitor, MATERIALS AND METHODS termed calpastatin, for calcium-dependent cysteine protease (calpain, EC 3.4.22.17) was cloned by screening rabbit cDNA Purification of Calpastatin from Rabbit Liver and the libraries with a synthetic oligodeoxynudeotide probe based on Designing of an Oligodeoxynucleotide Probe. Calpastatin was the amino acid sequence of the purified protein. The purified from rabbit liver essentially as described (13). The partial purified inhibitor gave a single band on NaDodSO4/poly- deduced amino acid sequence contains 718 amino acid residues acrylamide gel electrophoresis, and its various properties (Mr, 76,964), and the mature protein corresponds to the were similar to those of the human liver inhibitor (13). deduced sequence from the 80th residue of the primary Purified calpastatin was digested with trypsin or endopep- translation product (resultant Mr, 68,113). This deduced mo- tidase Arg-C (Boehringer Mannheim), and then the peptides lecular weight is significantly lower than that determined by generated were separated by HPLC on a Hitachi Gel 3063 NaDodSO4/polyacrylamide gel electrophoresis, suggesting the column. -
A Factor X-Activating Cysteine Protease from Malignant Tissue
A factor X-activating cysteine protease from malignant tissue. S G Gordon, B A Cross J Clin Invest. 1981;67(6):1665-1671. https://doi.org/10.1172/JCI110203. Research Article A proteolytic procoagulant has been identified in extracts of human and animal tumors and in cultured malignant cells. It directly activated Factor X but its similarity to other Factor S-activating serine proteases was not clear. This study describes work done to determine whether this enzyme, cancer procoagulant, is a serine or cysteine protease. Purified cancer procoagulant from rabbit V2 carcinoma was bound to a p-chloromercurialbenzoate-agarose affinity column and was eluted with dithiothreitol. The initiation of recalcified, citrated plasma coagulation activity by cancer procoagulant was inhibited by 5 mM diisopropylfluorophosphate, 1 mM phenylmethylsulfonylfluoride, 0.1 mM HgCl2, and 1 mM iodoacetamide. Activity was restored in the diisopropylfluorophosphate-, phenylmethylsulfonylfluoride-, and HgCl2- inhibited samples by 5 mM dithiothreitol; iodoacetamide inhibition was irreversible. Russell's viper venom, a control Factor X-activating serine protease, was not inhibited by either 0.1 mM HgCl2 or 1 mM iodoacetamide. The direct activation of Factor X by cancer procoagulant in a two-stage assay was inhibited by diisopropylfluorophosphate and iodoacetamide. Diisopropylfluorophosphate inhibits serine proteases, and an undefined impurity in most commercial preparations inhibits cysteine proteases. Hydrolysis of diisopropylfluorophosphate with CuSO4 and imidazole virtually eliminated inhibition of thrombin, but cancer procoagulant inhibition remained complete, suggesting that cancer procoagulant was inhibited by the undefined impurity. These results suggest that cancer procoagulant is a cysteine endopeptidase, which distinguishes it from other coagulation factors including tissue factor. -
The Cysteine Protease–Cysteine Protease Inhibitor System Explored in Soybean Nodule Development
Agronomy 2013, 3, 550-570; doi:10.3390/agronomy3030550 OPEN ACCESS agronomy ISSN 2073-4395 www.mdpi.com/journal/agronomy Discussion The Cysteine Protease–Cysteine Protease Inhibitor System Explored in Soybean Nodule Development Barend Juan Vorster 1,†, Urte Schlüter 2,†, Magdeleen du Plessis 1, Stefan van Wyk 1, Matome Eugene Makgopa 2, Ignatious Ncube 3, Marian Dorcas Quain 4, Karl Kunert 2 and Christine Helen Foyer 4,* 1 Department of Plant Production and Soil Science, Forestry and Agricultural Biotechnology Institute, University of Pretoria, Pretoria 0002, South Africa; E-Mails: [email protected] (B.J.V.); [email protected] (M.P.); [email protected] (S.W.) 2 Department of Plant Science, Forestry and Agricultural Biotechnology Institute, University of Pretoria, Pretoria 0002, South Africa; E-Mails: [email protected] (U.S.); [email protected] (M.E.M.); [email protected] (K.K.) 3 Biotechnology Unit School of Molecular and Life Sciences, University of Limpopo, Sovenga 0727, South Africa; E-Mail: [email protected] 4 Center for Plant Sciences, Faculty of Biology, University of Leeds, Leeds, LS2 9JT, UK; E-Mail: [email protected] † These authors contributed equally to this work. * Author to whom correspondence should be addressed; E-Mail: [email protected]; Tel.: +44-113-343-1421; Fax: +44-113-343-2882. Received: 29 May 2013; in revised form: 12 July 2013 / Accepted: 22 July 2013 / Published: 20 August 2013 Abstract: Almost all protease families have been associated with plant development, particularly senescence, which is the final developmental stage of every organ before cell death. -
Proteolytic Allergen Proder P 1, a Major House Dust Mite the Crystal
The Crystal Structure of Recombinant proDer p 1, a Major House Dust Mite Proteolytic Allergen This information is current as Kåre Meno, Peter B. Thorsted, Henrik Ipsen, Ole Kristensen, of September 26, 2021. Jørgen N. Larsen, Michael D. Spangfort, Michael Gajhede and Kaare Lund J Immunol 2005; 175:3835-3845; ; doi: 10.4049/jimmunol.175.6.3835 http://www.jimmunol.org/content/175/6/3835 Downloaded from References This article cites 49 articles, 10 of which you can access for free at: http://www.jimmunol.org/content/175/6/3835.full#ref-list-1 http://www.jimmunol.org/ Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication by guest on September 26, 2021 *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2005 by The American Association of Immunologists All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. The Journal of Immunology The Crystal Structure of Recombinant proDer p 1, a Major House Dust Mite Proteolytic Allergen1 Kåre Meno,2* Peter B. Thorsted,* Henrik Ipsen,* Ole Kristensen,† Jørgen N. Larsen,* Michael D.